SC BIO
SCbio is an investor-driven, member-based life sciences industry association and economic development organization focused on advancing South Carolina’s life sciences ecosystem. The organization convenes industry, academia, government and startups to promote workforce development, entrepreneurship, business recruitment, policy advocacy, industry marketing, shared laboratory infrastructure, and member services to grow biotech, pharma, medical device, digital health and related sectors in the state.
Industries
N/A
Nr. of Employees
small (1-50)
Services
Tiered membership delivering access to events, networking, marketing exposure, policy engagement, savings programs and member-only resources.
Accelerator program providing mentorship, investor connections and commercialization support for selected biotech and techbio startups.
Connects companies to leasable wet-lab and office spaces in state lab hubs and provides landing space and programming for early-stage companies.
A group health plan designed for small and mid-sized life science organizations providing large-group underwriting and benefit-rich plan options.
Organizes regional and statewide events, including an annual Life + Science conference and participation at national conventions to convene stakeholders.
Provides subject-matter expertise and support for recruiting life sciences companies and advising on site visits and incentives.
Tiered membership delivering access to events, networking, marketing exposure, policy engagement, savings programs and member-only resources.
Accelerator program providing mentorship, investor connections and commercialization support for selected biotech and techbio startups.
Connects companies to leasable wet-lab and office spaces in state lab hubs and provides landing space and programming for early-stage companies.
A group health plan designed for small and mid-sized life science organizations providing large-group underwriting and benefit-rich plan options.
Organizes regional and statewide events, including an annual Life + Science conference and participation at national conventions to convene stakeholders.
Provides subject-matter expertise and support for recruiting life sciences companies and advising on site visits and incentives.
Expertise Areas
- Workforce development for life sciences
- Startup acceleration and commercialization support
- Economic development and company recruitment
- Industry advocacy and public policy engagement
Key Technologies
- Advanced biomanufacturing
- Digital health and health data platforms
- Clinical diagnostics and laboratory testing
- Peptide API GMP manufacturing
News & Updates
Coverage of an NIH award to MUSC to establish a precision neurorehabilitation research center focused on neuromodulation and neural-circuit-based interventions.
Article reporting FDA orphan drug designation for a preclinical immunotherapy candidate targeting acute myeloid leukemia.
Announcement and summary of the CSBI/TEConomy 2023 workforce trends report providing national analysis of talent needs and labor market trends in the life sciences.
Announcement that a corporate member elevated membership to Founding Partner level and added leadership to SCbio’s Strategic Advisory Board.
Report on a multinational pharmaceutical company's planned investment in U.S. medicines manufacturing and research capacity.
Announcement of a contract development and manufacturing organization completing acquisition of a consumer-health manufacturing site in Aiken, South Carolina.
Coverage of an NIH award to MUSC to establish a precision neurorehabilitation research center focused on neuromodulation and neural-circuit-based interventions.
Article reporting FDA orphan drug designation for a preclinical immunotherapy candidate targeting acute myeloid leukemia.
Announcement and summary of the CSBI/TEConomy 2023 workforce trends report providing national analysis of talent needs and labor market trends in the life sciences.
Announcement that a corporate member elevated membership to Founding Partner level and added leadership to SCbio’s Strategic Advisory Board.
Report on a multinational pharmaceutical company's planned investment in U.S. medicines manufacturing and research capacity.
Announcement of a contract development and manufacturing organization completing acquisition of a consumer-health manufacturing site in Aiken, South Carolina.